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 i 
Abstract 
Angiogenesis, the formation of new blood vessels sprouting from existing ones, 
occurs in several situations like wound healing, tissue remodeling and near growing 
tumors. Under hypoxic conditions tumors secrete VEGF which activates endothelial 
cells (ECs) in nearby vessels, leading to the migration of ECs out of the vessel and the 
formation of growing sprouts. Several mechanisms are involved in angiogenic EC 
migration, such as chemotaxis, haptotaxis, haptokinesis and proteolysis of the 
extracellular matrix (ECM). In this thesis we present a cell based model of 
angiogenesis, based on the Cellular Potts Model (CPM), which includes these 
mechanisms in simple rules. We show that this simple set of rules is sufficient to form 
sprouts and even branching vascular networks. 
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C h a p t e r  1   
Introduction 
1.1 Background 
Angiogenesis, the formation of new blood vessels sprouting from existing vessels, is 
an important process during development, reproduction and tissue repair. However, 
angiogenesis can also be a pathological process. For example, it is required for tumors 
to sustain their growth. A lot of research has been done to get more insight in this 
process, to find the major regulators of angiogenesis and to learn about the 
mechanisms involved in the initiation, elongation and branching of new blood vessel 
sprouts. This knowledge could for instance help finding new therapies against cancer 
[1-3]. 
1.2 Scope and Objective 
In this thesis we will discuss what is known today about angiogenesis, in particular the 
process of blood vessel formation induced by growing tumors. We will focus on the 
chemical and mechanical mechanisms that regulate the directional migration and 
proliferation of endothelial cells, the cells that form a new growing blood vessel 
sprout. 
In particular we are interested in the interactions between endothelial cells and the 
extracellular matrix. How do cells respond to the composition of the matrix and in 
what way does this influence the growth and branching of a new sprout? Can these 
interactions explain characteristics of sprouting angiogenesis? 
We developed a cell based model to find answers to these questions. Cell-based 
models describe cell behaviors, including cell-cell interactions and the interactions of 
individual cells with their micro-environment, in terms of simple sets of rules. Thus 
cell-based models can give new insights in the mechanisms which are important for 
sprout formation and branching [4].  
Introduction Chapter 1 
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1.3 Organization of rest of thesis 
In the following chapter we will give an overview of the processes involved in 
sprouting angiogenesis. We will focus on the interactions between cells and the 
extracellular matrix. In chapter 3 we will discuss and compare existing models of 
angiogenesis. Next we present our cell-based model of angiogenesis and describe the 
process of translating experimental observations and biological theories into a model. 
In the final chapters we will present the simulation results, discuss our model and give 
suggestions for improvements. 
 3 
C h a p t e r  2    
Cell-matrix interactions during angiogenesis 
2.1 Hypoxic tumors induce angiogenesis 
Small tumors up to a size of ~1 mm can absorb, by simple diffusion, sufficient 
oxygen and nutrients from their direct environment. When a tumor grows beyond 
this size tumor cells will lack oxygen and become hypoxic. This turns on the so-called 
'angiogenic switch', which leads to an increased expression of several angiogenic 
factors [5-6].  
One of the key angiogenic factors is vascular endothelial growth factor (VEGF). With 
VEGF we usually mean VEGF-A, which is a member of the VEGF family. VEGF-A 
has several isoforms, resulting from alternative splicing. A number of these isoforms 
have a heparin-binding domain and bind to the extracellular matrix (ECM), others are 
soluble factors [6].  
VEGF released by a tumor diffuses into the surrounding tissue, establishing a 
chemical gradient between the tumor and nearby blood vessels. When it reaches a 
vessel, it binds to cell surface receptors on endothelial cells (ECs) which form the 
inner lining of blood vessel walls. This activates the ECs, resulting in increased cell 
survival, migration and proliferation [7]. 
ECs activated by VEGF first degrade the basement membrane of the parent vessel 
and then migrate into the extracellular matrix (ECM) towards the tumor. First, small 
sprouts are formed by aggregation and migration of ECs that are recruited from the 
parent vessel. The sprout will further extend when some of the ECs in the sprout wall 
begin to divide [5, 8]. During this process the vessel sprout will form new branches, 
and these branches can reconnect again, a process called anastomosis. Recently, Fantin 
and co-workers reported that macrophages can act as ‘bridge-cells’ in this process, 
mediating the fusion of the tips of two sprouts [9]. Finally the vascular tree reaches 
Cell-matrix interactions during angiogenesis Chapter 2 
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the tumor, providing it with nutrients and oxygen. Once vascularized, a tumor is more 
likely to become malignant and to spread and metastasize to other parts of the body 
[10]. 
2.1.1 Endothelial cells take on different roles 
During angiogenesis ECs can have different phenotypes [11-12]. Cells at the tip of the 
sprout, tip cells, lead the new formed vessel. Their task is to navigate and they actively 
extend filopodia, which are spiky protrusions, to sense and respond to guidance cues 
in their environment. They can secrete proteases to degrade the extracellular matrix. 
Tip cells do not proliferate (grow and divide). 
Stalk cells are cells trailing the tip cells. They are less motile and they barely extend 
filopodia. Stalk cells proliferate when stimulated with VEGF [13] and they deposit 
ECM components. Their task is to elongating the stalk, to form lumen and connect to 
the circulation.  
Once the vessel has formed, cells turn into the phalanx phenotype; they become 
quiescent and mostly stop dividing. The key function of the vessel is then to supply 
blood and oxygen to tissues [12].  
Tip cell selection and induction is regulated with the endothelial DLL4/NOTCH 
pathway, which is stimulated by VEGF. This signaling pathway inhibits tip cell 
formation near other tip cells through lateral inhibition [11]. 
2.1.2 Proliferation is required to reach the tumor 
Sprouting is possible without proliferation of stalk cells. However proliferation is 
necessary to sustain sprouting for a longer period and to grow a large enough sprout 
that can reach the tumor. [7, 10] 
Although the general idea is that proliferation occurs behind the tip cell, there is no 
consensus about the exact location of EC mitosis during angiogenesis. Experiments 
have shown that proliferation can occur some distance behind the sprout tip [10, 14], 
at the base of a new sprout [10, 15], and even at the tip of the sprout [8, 15-16].  
Chapter 2 Cell-matrix interactions during angiogenesis 
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Several studies suggest that proliferation only occurs when the connection between 
adjacent cells has been disrupted. Therefore it is possible that during angiogenesis 
mitosis occurs as a result of gaps between ECs in the new sprout [8].  
2.1.3 The extracellular matrix has many roles in angiogenesis  
The extracellular matrix is a mesh-like network of macromolecules secreted locally by 
cells. The main components of the ECM are proteoglycans, fibrous proteins such as 
collagen and elastin and adhesive proteins like laminin and fibronectin. In vertebrates 
the ECM constitutes the major part of the connective tissue and it forms the 
basement membrane (or basal lamina), which is a thin sheet of ECM underlying 
epithelial cells  [17].  
The ECM has many roles in angiogenesis. It is essential for EC migration, 
proliferation and survival, since it provides structural support and chemical cues for 
cell adhesion and motility. ECM components like collagen I and fibrin are capable of 
supporting chemotactic migration. The density and spatial distribution of ECM 
proteins such as fibronectin and collagen can affect the speed and direction of cell 
migration. Furthermore, ECs are able to secrete and degrade ECM components [18].  
2.2 Cells migrate by attachment to the ECM 
Many studies of cell migration describe in vitro experiments where cells are plated on 
a dish coated with ECM components. In other experiments, cells are seeded in a three 
dimensional matrix, in which they show distinct migrating behavior.  
The following steps describe how cells move on two-dimensional substrata. First they 
extend filopodia to sense signals like VEGF gradients in their direct environment. 
Then sheet-like extensions, called lamellipodia, will form dynamic attachments to the 
ECM at the front of the cell. Next the stress fibers within the cell contract, which 
results in a detachment of the rear of the cell. Finally the cytoskeleton relaxes, 
adhesive and signaling components are recycled and the cell repeats the cycle. [19]. 
Cell-matrix interactions during angiogenesis Chapter 2 
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In three-dimensional situations cells behave differently. They have a more elongated 
and spindle-like shape due to the physical restriction of matrix fibrils. Instead of 
extending lamellipodia, the cells form pseudopodia following the direction of matrix 
fibrils. Migrating cells in a 3D matrix have less stress fibers, focal adhesions and 
spreading. Because the 3D matrix forms a physical barrier around the cells, proteolysis 
of ECM by cells is necessary for motility [20]. 
Cells attach to the ECM by reversibly binding transmembrane receptors, mostly 
integrins, to ECM proteins. The integrin family includes more than 20 members. They 
bind their extracellular domain to specific ligands such as fibronectin, collagen and 
laminin and cluster in the membrane to form adhesive contacts called focal adhesions. 
During EC migration focal adhesions and stress fibers are aligned in the direction of 
movement resulting in polarized cells [19].  
Cell-ECM adhesions regulate cell migration in two ways. They have an adhesive 
function, binding the extracellular matrix to the actin cytoskeleton, and a signal 
transduction function, regulating molecules important for cell motility [20].  
VEGF can stimulate cell migration in several manners. It increases the expression and 
activation of several integrins involved in angiogenesis. Cell-cell adhesions inhibit cell 
migration and need to be broken down to allow cells to migrate. VEGF can break 
endothelial cell-cell contacts by disrupting the VE-cadherin/β-catenin complex at 
adherens junctions [19]. 
2.3 Cell migration is directed by chemotaxis 
Chemotaxis is the directional migration of cells in response to gradients of extracellular 
soluble chemicals. Various cytokines regulate chemotactic migration of ECs, but the 
three key players are VEGF, bFGF (basic fibroblast growth factor) and angiopoietins 
[19]. 
In their study of retinal angiogenesis Gerhardt et al. demonstrated that VEGF 
independently regulates EC migration of tip cells and proliferation of stalk cells 
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(Gerhardt, Golding et al. 2003). Their experiments showed that endothelial tip cells 
extend long filopodia in response to VEGF. These filopodia were guided by a VEGF 
gradient, resulting in the directed migration of the tip cells (Figure 1). However stalk 
cell proliferation did depend on the actual concentration of VEGF instead of the 
gradient. Both functions are mediated by the receptor VEGFR2, but the signals seem 
to be interpreted differently by the two EC subtypes. 
 
Figure 1 VEGF gradients are necessary for directed tip 
cell filopodia extension. (From [13]). 
Barkefors et al. used a microfluidic chemotaxis chamber (MCC) to study EC 
migration in response to different VEGF gradients [21]. They observed that a stable 
gradient of both the isoforms VEGF165 and VEGF121 is sufficient to induce 
chemotaxis of ECs. Since VEGF121 is unable to interact with several coreceptors, 
this proved that a stable gradient of VEGF suffices for chemotaxis and interactions 
between VEGF and coreceptors are not required for a chemotactic response. 
Furthermore, the authors identified a minimal gradient steepness required for 
induction of chemotaxis and they showed that chemotaxis is reduced when cells reach 
the high end of the VEGF gradient. The experiments demonstrated that the shape of 
the VEGF gradient controls the migratory response of ECs. 
2.4 Haptotactic migration can play a role in angiogenesis 
The local degradation and deposition of matrix proteins by ECs and the heterogeneity 
of the extracellular matrix can all create local gradients of ECM components which 
Cell-matrix interactions during angiogenesis Chapter 2 
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can drive endothelial cell migration, a process called haptotaxis. Haptotaxis of ECs is 
mainly triggered by the adhesive interactions between ECM components and integrins 
[19].  
While the role of haptotactic migration in angiogenesis has not yet been established 
[18], in vitro experiments have shown that collagen [22] and fibronectin [23-24] 
gradients can guide EC migration, and therefore it is plausible that gradients of these 
components in vivo may lead to haptotaxis as well. 
Senger et al. studied the function of two specific integrins in haptotactic migration of 
ECs in a gradient of immobilized collagen I [22]. Addition of antibodies against these 
integrins resulted in a significant reduction of directed migration towards collagen. 
Smith et al monitored ECs on substrates with linear gradients or uniform 
concentrations of fibronectin in a highly controlled environment [23]. The 
experiments demonstrated that the drift speed of ECs increased on fibronectin 
gradients compared to uniform substrates. In a subsequent study they measured the 
response of cells to a range of fibronectin gradient slopes [24]. They showed that the 
cellular drift speed increased linearly with haptotactic gradient slope.  
2.5 Haptokinesis: Cell sensitivity to ECM concentrations 
While haptotaxis is the directional migration of cells up ECM gradients, haptokinesis 
is the sensitivity of cells to absolute concentrations of ECM components. Several 
experiments demonstrated that cell speed, spreading and membrane activity show a 
biphasic dependence on ECM concentrations, both on 2D substrates [25-30] as in 3D 
matrices [31]. We will describe some of these experiments and give possible 
explanations for the experimental observations. In chapter 4 we will describe our 
computational single cell experiments with which we tested each of these hypotheses. 
2.5.1 Haptokinesis explained with the detachment theory 
Palecek et al. measured the mean speed of migrating CHO (Chinese hamster ovary) 
cells plated on different concentrations of fibronectin and fibrinogen [28]. This speed 
Chapter 2 Cell-matrix interactions during angiogenesis 
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was maximal at intermediate ECM ligand concentrations regardless of integrin 
expression level or integrin-ligand binding affinity. At lower ligand levels cells were 
more rounded and extended more unstable lamellae that couldn’t move the cell body. 
At high ligand levels cells were very spread and extended lamellae similar to migrating 
cells, but the cell body didn’t move very well. 
In another study [27] DiMilla and coworkers showed that the migration behavior of 
Human Smooth Muscle Cells (HSMCs) on substrates coated with the ECM proteins 
fibronectin and collagen IV, varied with the concentration of each matrix protein, 
showing again a biphasic dependence: cell speed and persistence time reached a 
maximum at intermediate concentrations of both proteins. 
Cells migrate at maximum speed at intermediate levels of adhesiveness. The general 
explanation for this behavior, which we shall call the ‘detachment theory’, is the idea 
that at low ECM densities, a cell cannot form strong and stable adhesions at the front 
to generate a traction force, so no movement is possible and the cell spreads poorly. 
At high densities a cell cannot detach adhesions from the substrate and therefore the 
cell will be well spread and immobilized, so again locomotion does not occur. 
Consequently cells have maximal migration speed at intermediate ECM densities, 
because then they are able to form new adhesions at the front, and are also able to 
break attachments at the rear [27-28, 32]. 
Cell-matrix interactions during angiogenesis Chapter 2 
 10 
  
 (a) (b) 
Figure 2 Maximal (a) cell speed [28] and (b) spreading  
[29] at intermediate ECM concentrations.  
2.5.2 Haptokinesis explained with the receptor saturation model 
Although in Palecek’s experiments [28] cells were most spread on high ECM 
densities, Gaudet et al. presented experimental results where both cell spreading and 
speed were maximal at intermediate collagen surface densities [29]. They measured the 
projected area, migration speed and traction force at various type I collagen surface 
densities in a population of fibroblasts. Initially the cell area was an increasing 
function of surface density, but above a certain concentration the area declined. This 
threshold collagen density was approximately equal to the cell surface density of 
integrin molecules. 
The ‘receptor saturation’ model can explain these observations [29]. At low densities, 
the number of ligands available to a cell is low, and therefore the cell cannot spread 
effectively. With increasing densities, more integrins can bind to ligands, leading to 
increased spreading. At the transition point all the integrins on the cell are bound to 
the substrate. Further spreading is impossible since there are no free integrins 
available. If the collagen density is increased beyond this point, the saturation of 
integrin receptors will be possible with a lower level of spreading. So the cell is less 
spread even though the substrate is more adhesive. 
Chapter 2 Cell-matrix interactions during angiogenesis 
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2.5.3 Haptokinesis explained with altered signaling 
In the study of Cox et al. cells were plated on different concentrations of fibronectin 
[26]. The authors reported that membrane activity was maximal at intermediate 
substratum concentrations. Cell spreading, however, was optimal at high substratum 
concentrations and lower at intermediate and very high concentrations. 
Members of the Rho family play an important role in regulating migration. For that 
reason Cox and coworkers measured the activity of the genes Cdc42, Rac1 and RhoA 
in their experiments. The activation of Cdc42 and Rac1 showed a biphasic depen-
dence on fibronectin concentration in line with optimum cell polarization and 
protrusion. RhoA activity remained elevated at higher substratum concentrations. 
Their findings suggest that adhesion-dependent signaling is a mechanism to stop cell 
migration by regulating cell polarity and protrusion via genes of the Rho family. Cox 
and coworkers imply with their study another mechanism to explain the haptokinetic 
observations, which we will refer to as ‘altered signaling’.  
2.6 Other mechanisms can influence cell migration 
Apart from chemotaxis, haptotaxis and haptokinesis, several other mechanisms can 
regulate the migration of ECs. For example shear stress mechanically influences the 
response of ECs to haptotactic and chemotactic signals [19]. Aligned fibers in the 
ECM can guide cell migration (topographic guidance) and these guiding structures can 
in turn be remodeled by EC tip cells[20]. Differences in ECM rigidity or stiffness can 
also direct migration, a process called ‘durotaxis’ [20, 31]. 
2.7 ECs secrete proteolytic enzymes in order to degrade the ECM 
Sprouting endothelial cells must break through their basement membrane and invade 
into the extracellular matrix in order to form a new capillary. This process requires 
proteolytic degradation of the ECM [33].  
Endothelial tip cells express matrix metalloproteinases (MMPs) that can break down 
ECM components. MMPs are a family of more then 20 zinc-dependent enzymes. 
Cell-matrix interactions during angiogenesis Chapter 2 
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They can be divided into two structurally different groups, the secreted MMPs and 
membrane-type MMPs (MT-MMPs). Together the MMPs can degrade all known 
mammalian extracellular matrix proteins. This includes fibrin, whose breakdown was 
usually ascribed solely to plasmin, another important proteolytic enzyme [33-34]. 
Most MMPs -except for the MT-MMPs- are secreted by the cell as latent enzymes.  
Their activation occurs in the extracellular compartment; MT-MMPs are activated 
inside the cell. The activity of MMPs is furthermore regulated by tissue inhibitors of 
metalloproteinases, TIMPs. Cells can localize the proteolysis of extracellular matrix to 
specific areas of the cell surface, such as the leading tip of a migrating cell, by fine-
tuning the interactions with receptors and inhibitors. This increases the efficiency of 
invasion while preventing the destruction of the required matrix scaffold [33-35]. 
MT1-MMP is generally considered to be the most important player in pericellular 
proteolytic activity and is essential in the migration of cells in type I collagen [33, 36-
37]. MT1-MMP can degrade many ECM proteins, including collagens, gelatin, and 
fibronectin. It associates with the plasma membrane, resulting in matrix degradation 
close to the cell surface. Furthermore it can activate MMP-2 and MMP-13 which 
amplifies the proteolytic process [33-34].  
MMPs, especially MMP-2, MMP-9 and MT1-MMP, appear to be required for 
angiogenesis. Quiescent ECs produce little or no MMPs, but during wound healing, 
inflammation and tumor growth MMPs are strongly induced and activated in capillary 
sprouts [33-34]. Furthermore, several studies have shown that MMP inhibitors could 
inhibit angiogenesis [34-35]. Activation of proteases can be induced by angiogenic 
growth factors and inflammatory cytokines. For example MT1-MMP is induced in 
ECs by several factors, such as VEGF and HGF (hepatocyte growth factor) [33-34]. 
2.7.1 Other functions of MMPs and their proteolytic products 
It was long thought that the only function of MMPs was to degrade ECM 
components. Recent studies however show that extracellular proteolyses can also 
regulate endothelial cell function in a more indirect way. 
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Growth factors bound to ECM components can be released by MMPs. For example, 
Hawinkels et al. reported that MMP-9 can release matrix-bound VEGF, making it 
more available to VEGF receptors [38]. Furthermore several angiogenic growth 
factors like VEGF and TGF-b (transforming growth factor beta) require proteolytic 
processing to become active [33]. 
Proteolytic fragments of the ECM and other molecules have been reported to show 
regulatory activity in angiogenesis, either positive or negative. They are often called 
‘matrikines’ [33]. 
2.8 Summary 
In this chapter we discussed some of the main mechanisms that are involved in tumor 
induced angiogenesis. One of the key players is VEGF. First of all it activates ECs, 
promoting their proliferation, survival and migration. Furthermore, the migration of 
ECs is guided by VEGF gradients between the tumor and the parent vessels. In 
addition VEGF promotes ECM degradation by stimulating the expression of MMPs. 
Angiogenesis depends on highly regulated interactions between cells and the 
extracellular matrix. In order to invade the ECM, cells need to break down ECM 
components, but cell-ECM adhesions are required for cell motility. Cell speed and 
migration direction is influenced by concentrations and gradients of ECM densities. 
To what extent play chemotaxis, haptotaxis, haptokinesis and proteolysis a role in 
sprouting angiogenesis? Are they sufficient mechanisms for the growth of new vessel 
sprouts and the formation of branching vascular structures? Mathematical models of 
angiogenesis can be a means to answer these questions. In the next chapter we will 
discuss several existing models of angiogenesis.  
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C h a p t e r  3   
Models of  angiogenesis 
3.1 The position of modeling in angiogenesis research 
Mathematical models of angiogenesis can offer insight into the processes driving 
angiogenesis, and test or propose new hypotheses. Many models have been developed 
of angiogenesis over the last 30 years [39]. This was enabled by the boost in available 
biological data on this topic and the increasing computational capabilities.  
Since tumor angiogenesis is a complex process, the models to date only address a part 
of the aspects involved in angiogenesis. By focusing on specific mechanisms that can 
influence the formation of capillary sprouts, these models can help to find the 
necessary conditions that are required for angiogenesis, such as cell proliferation, 
haptotaxis, haptokinesis or chemotaxis.  
A model is of most value if it is able to reproduce experimental observed phenomena, 
without explicitly prescribing such events. Such a model should be able to produce 
emergent behavior from lower level rules. For example, many models of sprouting 
angiogenesis use high-level rules for branching. We will discuss some of them in the 
next section. In these models branching is not an emerging phenomenon, but a 
prescribed event.  
In this chapter we will discuss three model categories: continuum models, discrete 
models and hybrid models (Figure 3). We will describe examples of each category and 
discuss the advantages and disadvantages of these types of models. We will focus on 
how cell-ECM interactions are incorporated and whether and how branching occurs 
in these models. 
The Cellular Potts model (CPM) is a cell based framework frequently used to model 
all kinds of biological phenomena. We will conclude this chapter with a short 
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description of the CPM and a review of a number of models of angiogenesis based on 
the CPM. 
3.2 Continuum models 
Continuum models represent new blood vessels in terms of cell densities, using partial 
differential equations (PDEs) to describe the average migration and proliferation of 
cell populations. In these models areas with high densities are blood vessels. Several 
models make a distinction between the tip and the stalk of a sprout, assuming that tip 
cells guide the sprout which is formed just behind it. 
Although continuum models can provide valuable insight into aspects of 
angiogenesis, the disadvantage of these models is their use of cell densities and PDEs. 
This assumes a large amount of cells to be involved in the process, whereas sprouting 
angiogenesis concerns a limited number of endothelial cells. As a result continuous 
models cannot take individual cell interactions and behaviors into account. In 
addition, these models are not able to predict the actual tree-like vascular structure, 
because they do not distinct separate sprouts. 
3.2.1 A study of chemotaxis and haptotaxis in angiogenesis 
The two-dimensional continuum model of Anderson and Chaplain [40] uses PDEs to 
describe EC, tumor angiogenic factor (TAF) and fibronectin densities. EC migration 
at the tip of a sprout is influenced by three factors: random motility, (saturated) 
chemotaxis towards TAF and haptotaxis towards fibronectin. In this model cells do 
not proliferate. The model incorporates uptake of TAF and fibronectin by ECs.  
An important result from simulations was that for the outgrowth of the capillary 
network a sufficient strong chemotactic response was essential. The interactions 
between ECs and the ECM were important as well. The uptake of fibronectin and 
TAF created local gradients that allowed for lateral movement. Without this 
haptotactic response, cells migrated directly to the tumor. 
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The model contradicts experimental observations on two points: the speed of the 
vascular front decreases when approaching the tumor, while in reality the speed 
increases [39]. Second, although the model has not included proliferation, it produces 
vessels that in some cases reach the tumor, which disagrees with experimental 
observations as well [10].  
Furthermore, this model is not able to capture relevant processes that happen on a 
smaller scale, such as sprout branching. Therefore the continuum model was 
converted to a discrete model, applicable at the level of a single cell. This model will 
be discussed in the next section where we describe discrete models. 
3.2.2 Modeling the onset of angiogenesis 
Levine et al. [41] presented a one-dimensional continuum model that describes the 
onset of angiogenesis. It concentrates on the first phase of neovascularization, namely 
the changes within the existing vessel. The model tries to predict the site of sprout 
formation. 
In the model EC migration is considered to be a diffusive process which can be 
modeled with a PDE describing reinforced random walks where transition 
probabilities are dependent on cell concentration, proteolytic enzymes and fibronectin 
that forms the basal lamina. Michaelis-Menten kinetics describe reactions in which EC 
receptors are regarded as catalysts for converting TGF (tumor angiogenic growth 
factors) into proteolytic enzyme, which in turn breaks down fibronectin and destroys 
the basal lamina. Secretion and uptake of fibronectin by ECs is modeled as well. The 
model also includes chemotaxis to TGF and haptotaxis to lower concentrations of 
fibronectin. 
Simulations demonstrated that if there was enough angiogenic growth factor supplied 
to the capillary wall, the basal lamina would break down. Inside the fibronectin 
opening two aggregated peaks of EC concentration arose, forming the lining of the 
growing new sprout.  
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3.2.3 Extending the model with EC migration into the ECM 
Levine and coworkers [42] coupled this one-dimensional model of the initiation of 
angiogenesis to a two-dimensional model that describes the migration of ECs into the 
ECM towards the tumor, using mostly the same cell behaviors and biochemical 
kinetics from the earlier model. 
In this complex model cells proliferate in the ECM in response to the proteolytic 
enzyme and this proliferation is localized behind the leading tip of the sprout. The 
complex structure of the ECM is accounted for using a porosity constant. 
The model uses a phenomenological approach where several experimental 
observations, such as the localization of proliferation and the acceleration of the 
growing sprout near the tumor, are explicitly included in the model. Therefore these 
observations cannot be predicted or understood with this model, they can only be 
accounted for [39].  
3.2.4 Mechanochemical forces in blood vessel formation 
The model presented by Manoussaki [43] considers both mechanical and chemical 
interactions during vasculogenesis (the formation of the initial vascualar network 
during development) and angiogenesis and investigates the effects of these 
mechanochemical forces on blood vessel formation. 
In this model ECs migrate in response to a chemoattractant source. The cells pull on 
the viscoelastic ECM and migrate by haptotaxis along the resulting ECM stress lines. 
This results in narrow vessel-like structures. Cell, ECM and chemoattractant densities 
are described with non-linear PDEs, containing advection, diffusion and reaction 
terms. 
The simulation results suggest that chemotaxis alone is not sufficient for sprout 
development and that other mechanisms play an important role as well, such as 
mechanical forces. The model predicts that chemotaxis together with cellular traction 
can be sufficient for blood vessel formation. 
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3.3 Discrete models 
Discrete models represent cells as single entities that can behave independently and 
move, grow and divide given certain prescribed rules. With discrete models one can 
define cell behaviors and interactions with their local environment in order to show 
how these can yield complex structures. Since a vessel sprout is normally one or a few 
cells wide and sprout formation involves stochastic mechanisms, cell-based models 
are better suited to describe the cellular dynamics during angiogenesis than continuum 
models, which describe sprouts as cell densities using deterministic differential 
equations. 
  
 
  
Figure 3 Top row left: continuum model by Levine et al. 
[42] Top row right: discrete model by Yin et al. [44] 
Bottom row left: hybrid model by Milde et al. [45] 
Bottom row right: discrete model by Anderson and 
Chaplain. [40] 
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3.3.1 A lattice free agent based model 
Stokes and Lauffenburger were one of the first to use a discrete model to describe 
angiogenesis [46]. They presented a two dimensional, lattice free, agent based model, 
where new blood vessel sprouts are defined by the trajectory of a migrating cell at the 
tip of the sprout. Cells within a sprout proliferate to enable sprout growth. Branching 
is incorporated with predefined branching probabilities. The migration of the tip cells 
is described by a stochastic ordinary differential equation, which includes chemotaxis 
and random motion. The model furthermore incorporates anastomosis and 
branching. 
The model investigates how EC motility characteristics like speed and persistence 
time and chemotactic responsiveness affect the growth rate and structure of the 
resulting network. The parameters describing random motility, chemotaxis and 
proliferation were obtained as much as possible from experimental observations of 
EC behaviors to preserve the predictive value of the model. However the budding 
and branching probabilities were estimated from experiments on angiogenesis, so 
these parameters are partly responsible for the ability to predict for example the 
average vessel lengths in the model. 
Simulations demonstrated that the migration rate of ECs mainly determined the rate 
of vessel outgrowth and that a directional movement, in this model provided by 
chemotaxis, was required for directed network growth. 
3.3.2 Discretizing the continuum model 
By discretizing the PDEs in their continuum model and translating them into 
movement probabilities, Anderson and Chaplain derived a discrete biased random 
walk model of angiogenesis [40].  
The model is based on the assumption that an endothelial cell at the tip of the sprout 
determines the motion of the whole sprout. In addition sprout branching, 
anastomosis and cell proliferation were incorporated in this model. The generation of 
new sprouts occurs at existing sprout tips and only when certain conditions on the 
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sprout age, EC density and available space are met. The probability that a branch is 
formed is dependent on the local TAF concentration. Proliferation is added to the 
model by allowing division of cells at the sprout tip when they are above a certain age. 
The results from simulations were similar to those from the continuum model, only 
now realistic networks were formed. Again, without haptotaxis, the sprout grows 
faster and there is less lateral movement and therefore less branching. The results 
confirm those from the continuum model that both chemotaxis and haptotaxis are 
necessary for the formation of vascular networks in tumor induced angiogenesis.   
The discrete model was able to reproduce realistic networks structures. It did 
reproduce anastomosis, the dendritic structure of the capillary network and the 
formation of the 'brush border', the increased branching density near the tumor [39]. 
3.3.3 Migration following collagen cues 
Yin and coworkers [44] used a novel microfluid device to study and quantify the 
behavior of individual cells in well-defined conditions. With these experiments they 
showed that on a single cell or cell-cell basis, cell migration speed and migration 
patterns are affected by secreted ECM components and VEGF. From these 
observations they extracted a set of rules and built a simple agent based model in 
order to investigate whether these rules are sufficient to reproduce branching patterns 
in angiogenesis.  
In this model ECs are represented by sites on a lattice and they secrete ECM 
components like collagen which serve as guidance cues for other cells. The cell speed 
is related to absolute concentrations of collagen with maximal speeds at intermediate 
concentrations. Cells respond to absolute concentrations of VEGF by progressively 
loosing their sensitivity to ECM (probably due to increasing ECM degradation). 
Furthermore ECs move chemotactically to higher VEGF concentrations. Cells can 
proliferate if they have only one neighbor. 
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Simulations were able to produce patterns resembling growing and progressively 
branching vessel sprouts. Yin and colleagues showed that no specific rules on 
branching and no heterogeneous ECM densities were required to form vascular 
branching patterns  
3.4 Hybrid models 
Hybrid models combine continuum and discrete models to represent endothelial cells 
and other components that play a role in angiogenesis.  
In the  deterministic 3D model of Milde and co-workers [45] stalk cells and molecular 
species (VEGF, MMPs and fibronectin) are described as densities whereas tip cells are 
represented as particles in a discrete, agent based model.  
The tip cells secrete MMPs and fibronectin and they bind VEGF. The model 
incorporates both soluble and matrix-bound VEGF isoforms; the latter are cleaved by 
MMPs. Tip cells migrate through the ECM, directed by chemotactic and haptotactic 
cues given by VEGF and fibronectin gradients. They define the morphology of the 
growing sprout. 
EC migration and branching is also influenced by the heterogeneity of the ECM, 
which is represented by randomly distributed fibers. In addition the fibers in the ECM 
act as binding sites to fibronectin and matrix bound VEGF. Branching occurs in this 
model in response to diverging migration directions given by the ECM fiber orien-
tations and the VEGF and fibronectin gradients. Simulations demonstrated that the 
number of branches depended on the matrix structure and the level of matrix-bound 
VEGF isoforms. 
3.5 The Cellular Potts Model 
The Cellular Potts Model (CPM), also known as the Glazier-Graner-Hogeweg (GGH) 
model, is a lattice based framework, which has frequently been used to model a broad 
variety of biological phenomena [47-50]. It was developed by Glazier and Graner and 
represents cell dynamics, like interactions between cells and changes in shape, in terms 
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of a generalized energy [50]. It finds the lowest energy of a system using a Monte 
Carlo simulation technique with Metropolis dynamics. 
The CPM has many advantages over other cell-based models. It is a simple model, 
which is easy to extend. The irregular stochastic cell membrane dynamics, like 
extensions and retractions of protrusions, are explicitly represented, which allows 
simulating cell interactions with their environment and mimicking the exploratory 
behavior of cells. 
3.5.1 CPM models of angiogenesis 
The CPM is used in several simulations of tumor induced angiogenesis. We will 
discuss four of them below (Figure 4), focusing on the objective of each study, the 
rules which where incorporated in the models to describe EC behavior during 
angiogenesis and some of the results. 
In their model of tumor-induced angiogenesis Bauer et al. [51] explicitly modeled the 
heterogeneous composition of the extracellular matrix. They defined endothelial cells, 
matrix fibers, interstitial fluid and tissue specific cells in the CPM, each having 
different adhesion energies and different elasticity’s. Haptotaxis is naturally 
incorporated through these adhesion terms, making cell-matrix bonds more favorable 
over cell-fluid bonds. In their model cells get activated by VEGF and become either 
tip cells that degrade the matrix and migrate chemotactically up VEGF gradients or 
stalk cells that grow and divide. Their simulations show that the model is able to 
reproduce realistic sprout morphologies. They show that inhomogeneities in the ECM 
can be a mechanism for branching. Furthermore their simulations show that steep 
VEGF gradients result in narrow sprouts and shallow gradients in more swollen 
sprouts, which is consistent with empirical observations [13].  
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Figure 4 CPM models of angiogenesis. Top row left: 
Bauer et al. [51] Top row right: Merks et al. [52] Bottow 
row left: Shirinifard et al. [53] Bottom row right: Szabo et 
al. [54] 
Merks et al. [52] developed a CPM model to investigate if ECs autonomously 
organize into vascular patters without prepatterns of morphogens. Furthermore, they 
asked whether vasculogenesis and angiogenesis are regulated by the same 
mechanisms, signals and cell behavior. In their model cells secrete a chemoattractant, 
which attracts surrounding cells. From experiments it is shown that chemotaxis is 
inhibited at cell-cell surfaces (contact inhibition) [55]. Therefore the CPM was 
extended with the rule that only in the case of extension or retraction at cell-ECM 
surfaces the chemotactic energy will be included in the calculation of the energy. Two 
scenarios were tested: one where cells both extent and retract along chemotactic 
gradients and one where retractions are chemotactically neutral. In either cases, both 
sprouting-angiogenesis and vasculogenesis occurred, but in the latter case higher 
intrinsic cell motilities were needed. Their results suggest that sprouting in aggregates 
of cells secreting a chemoattractant can occur because (at low cell motilities) the 
branching resembles a 'buckling instability' and (at high motilities) more shallow 
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gradients at protrusions make it more likely for cells to extend outward-directed 
pseudopods. 
Shirinifard et al [53] presented a 3D CPM model of tumor growth and tumor induced 
angiogenesis. The model focuses on the growth of a tumor in response to the supply 
of oxygen. Goal of their simulations was to get more insight in differences in tumor 
growth with our without angiogenesis. In the model ECs are also activated when 
VEGF concentrations exceed a certain threshold. Activated cells proliferate and 
chemotax up a VEGF gradient. The model incorporates contact-inhibited growth of 
neovascular cells. When the common surface area with other neovascular cells is less 
than a threshold, the cell grows, with a growth rate related to the VEGF 
concentration. The cells divide if their volume reaches a certain doubling volume. To 
self-organize the ECs into capillary-like networks, the model was extended with 
autocrine chemotaxis to a very short-diffusing chemoattractant, as described in [48]. 
The model neglects proteolytic activity of ECs.  
Szabo et al. [54] argued that during sprout formation stalk cells cannot be totally 
passive. If cell-cell adhesion is analogue to surface tension, then tip cells are not able 
to ‘pull’ the sprout forwards, because of the Plateau-Rayleigh instability. (Just like a 
falling stream of fluid breaks up into smaller packets with the same volume but less 
surface area.) Therefore the authors suggested that stalk cells move autonomously as 
well. They show with CPM simulations that cell-cell adhesion is insufficient to 
maintain cell supply to expanding sprouts; cells in sprouts have more cell-matrix 
boundaries than cells at the surface of an aggregate of cells which results in an 
increase in energy. They extended the CPM with leader cells, preferential attachment 
to elongated cells and cell polarity. Simulations yielded sprouting dynamics 
comparable to experimental observations. 
3.6 Summary 
Many models of angiogenesis have been developed to get more insight in the 
mechanisms involved in this process. In this chapter we discussed continuum, discrete 
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and hybrid models. We argued that cell based models are the best choice for modeling 
angiogenesis, since angiogenic sprouting involves only a few cells and we therefore 
need to able to define rules on the level of an individual cell. In particular, the CPM 
can be a good basis for this goal, since it explicitly models the irregularities in cell 
shape and behavior.  
Each of the discussed CPM models used different sets of rules on the level of 
individual cells to model sprout formation during angiogenesis. This shows that 
different mechanisms, such as matrix inhomogeneity, chemotaxis to autocrines, 
contact inhibition of chemotaxis, cell polarity, and preferential adhesion to elongated 
cells can all play a role in the formation of vascular patterns. 
In the next chapter we will present our model of tumor induced angiogenesis, where 
we focus on the interactions between ECs and the ECM. It is based on the CPM and 
extended with these cell-matrix interactions.  
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C h a p t e r  4   
A cell based model of  ECM-guided EC 
migration during angiogenesis 
Our model defines cell-matrix interactions on the level of individual cells to study the 
emerging complex organizations on tissue level. These interactions are chemotaxis, 
haptotaxis, haptokinesis and proteolysis. Simulations should be able to answer 
questions like: do these interactions suffice to reproduce aspects of sprouting 
angiogenesis? Do they provide sufficient explanation for the formation of branching 
vascular structures?  
Our model is based on the following rules: (1) Tumors secrete VEGF resulting in a 
VEGF gradient. (2) VEGF induces the secretion of MMPs by endothelial cells. (3) 
MMPs degrade ECM components near the cell surface. (4) Cells move along VEGF 
gradients and they (5) migrate towards higher ECM densities. (6) Cells speed and 
spreading are maximal at intermediate ECM densities and (7) cells proliferate if a large 
part of their surface is in contact with the ECM.  
We used a two dimensional Cellular Potts Model (CPM) to implement these rules, we 
therefore start with a detailed description of the CPM in the following section. Next 
we will describe how we incorporated our model into the CPM. We give a detailed 
survey of ways to model haptokinesis and their implementation in the CPM  
4.1 CPM explained in more detail 
In the Cellular Potts Model biological cells are represented as patches of lattice sites. 
Each cell has a unique index σ, which is assigned to every lattice site that is occupied 
by that cell. Furthermore the type of a cell σ is denoted with τ(σ). The extracellular 
matrix consists of all lattice sites not occupied by cells and is labeled with index σ=0 
and type τ=0. 
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The interfaces between neighboring lattice sites with unequal index σx ≠ σx’ represent 
membrane bonds and have a cell-type dependent adhesion energy given by Jτ(σx),τ(σx’) 
(Figure 5). 
An area constraint penalizes cell shapes deviating too much from their preferred area. 
To mimic cell elongation a length constraint is added [48]. The ECM has no area or 
length constraint. 
 
Figure 5 Adhesion energies at cell-cell and cell-matrix 
interfaces. 
The ‘effective energy’ is given with the CPM Hamiltonian: 
 
'
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(1 ) ( ) ' ( )H J a A l Lτ σ τ σ σ σ σ σ σ σ
σ σ
δ λ λ= − + − + −∑ ∑ ∑x x x x'
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 (4.1) 
where x and x’ are neighboring lattice sites; δx,y = {1 , x=y; 0, x≠y}; aσ is the current 
area of cell σ, Aσ its target area and λ the inelasticity; lσ represents the current length of 
cell σ, Lσ its target length and λ’ the strength of the length constraint.  
To mimic membrane extensions and retractions, we repeatedly attempt to replace the 
index σ of a random lattice site x by one of its random neighboring sites x’. 
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We calculate ∆H, the change in total effective energy if we performed the copy and 
accept the attempt with Boltzmann probability:   
 /
1 , if 0( )
, if 0H T
H
P H
e H−∆
∆ <∆ =  ∆ ≥
 (4.2) 
where T corresponds to the intrinsic motility of the cells. By accepting energetically 
unfavorable moves, we prevent the system from getting trapped in local energy 
minima. 
Chemotaxis can be incorporated by including an extra reduction in energy for 
extensions and retractions towards higher concentrations of a chemoattractant (as 
described in [49]): 
 ( ( ) ( '))chemotaxisH c cµ∆ = − −x x  (4.3) 
where x is the site into which neighbor x’ copies its spin, c(x) is the local 
concentration of chemoattractant at site x, and µ is the strength of the chemotactic 
response. 
4.2 Model setup 
Our model domain is a rectangular dish (size 500 µm × 700 µm) in which endothelial 
cells are placed behind a vessel wall situated at the ‘bottom’ of the dish. The cells can 
migrate through a gap in the wall into the ECM towards the ‘top’ of the dish in the 
direction of a tumor which we assume to be located beyond the top of the dish 
(Figure 6). We define only one type of cell, so we do not make a distinction between 
tip cells and stalk cells. 
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Figure 6 The simulation is initialized with ECs placed 
behind a vessel wall.  
A lattice site represents an area of 2 × 2 µm. We will set the target area Aσ = 50 lattice 
sites corresponding to 200 µm2 and the target length Lσ = 30 µm. We set the adhesion 
energy at cell-cell borders JCC =40 and the cell-matrix energy JCM = 25, in order to 
make attachments between cells slightly favorable over cell-matrix bonds. The 
intrinsic motility parameter T =100. 
When doing a copy attempt we select the source site from the twenty first to fourth 
nearest neighbors, to improve the isotropy. During a Monte Carlo Step (MCS) we 
carry out N copy attempts where N is the number of lattice sites. We define a high 
cell-border energy to prevent cells from adhering to the boundaries of the lattice.  
4.3 Modeling VEGF, MMPs and ECM concentrations 
We will include three layers in our model that describe the concentration of VEGF, 
MMPs and ECM. Since MMPs degrade the matrix components, and VEGF induces 
the secretion of MMPs, we need to allow crosstalk between these layers. This way we 
can relate the secretion rate of MMPs to the VEGF concentration, and the decay rate 
of ECM components to the MMP concentration.  
TUMOR 
x 
y 
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4.3.1 VEGF layer 
Since the tumor will be relatively large, we assume a constant linear VEGF gradient 
with equal concentrations at equal y positions throughout the simulation. Therefore 
we initialize the VEGF layer at the start of the simulation and do not alter it by 
diffusion, secretion or degradation at later steps (Figure 7). 
Given the diffusion coefficient D and the degradation rate ε of VEGF and the 
concentration at a starting point c(0), we can calculate the analytical solution of the 
gradient at steady state [56]. If the gradient is caused by diffusion and linear decay, the 
1D solution is: 
 /( ) (0) y Dc y c e λ λ
ε
−
= =with  (4.4) 
 
   
 (a) (b) 
Figure 7 The constant VEGF gradient (a) and initial 
ECM density (b). 
4.3.2 MMP layer 
We will describe the secretion, decay and diffusion of MMPs with a PDE model: 
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where cM(x,t) and cV(x,t) represent the concentration of MMPs and VEGF 
respectively at site x at time t ; αM_V, εM and DM are the secretion rate, decay rate and 
diffusion coefficient of MMP. Again, δx,y = {1 , x=y; 0, x≠y}, so secretion only occurs 
at lattice sites occupied by cells and degradation only occurs at ECM sites. 
4.3.3 ECM layer 
We initialize the ECM layer at the start of the simulation with a high uniform 
concentration outside the parent vessel, an intermediate concentration inside the 
vessel and a half circular gradient behind the gap (Figure 7). We assume that ECM 
components do not diffuse and that the decay rate solely depends on the 
concentration of MMPs: 
 
,0 ,0 _
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c t
c t c t
t σ σ
α δ δ ε∂ = − −
∂ x x
x
x x  (4.6) 
where cE(x,t) and cM (x,t) represent the concentration of ECM and MMPs respectively 
at site x at time t ; αE, εE_M  are the secretion rate and decay rate of the ECM 
components. 
Since in our model degradation only happens at ECM sites, the non-diffusible ECM 
components will not decay at lattice sites that are occupied by the cells of a growing 
sprout. Therefore we set the secretion rate αE = 0, creating an ECM concentration at 
cell sites being the net result of balanced secretion and decay. 
We did try an alternative solution by allowing degradation at cell sites and adding 
secretion of ECM components. However, to avoid a fast accumulation or decay of 
ECM components the secretion and decay rates needed to be well-tuned, resulting in 
a model that was very sensitive to both these parameters. 
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We solve the two PDEs numerically with a finite difference scheme on a similar 
lattice as the one used in the CPM with ∆x = 2 µm. We set ∆t = 2 seconds and run 15 
‘diffusion steps’ between subsequent MCS. We use fixed boundary conditions. To 
avoid instabilities we first check whether the combination of ∆t, ∆x and diffusion 
coefficient is small enough (Von Neumann stability analysis) to solve with a fast 
Forward Euler method. If not, we switch automatically to a Crank-Nicolson (CN) 
scheme. The CN method takes the ‘average’ of the explicit Forward Euler method 
and the implicit Backward Euler method, resulting in an accurate and unconditionally 
stable solution [57]. 
The VEGF, MMP and ECM concentrations are dimensionless and all have values 
between 0 and 1. As a consequence the secretion of MMPs will be suppressed as soon 
as local MMP concentrations exceed the maximum concentration, this agrees with the 
inhibition of proteolysis by TIMPS.  
4.4 Modeling chemotaxis and haptotaxis 
Since primarily the extending filopodia of (tip) cells are able to sense and react on 
chemotactic cues, we consider only extensions of cells into the ECM to contribute to 
the chemotaxis energy term.  
The energy change due to chemotaxis then becomes: 
 
'
,0 ,0(1 ) ( ( ) ( '))chemotaxis V VH c cσ σδ δ µ∆ = − − ⋅ −x x x x  (4.7) 
where x is the site into which neighbor x’ copies its spin, cV(x) is the local concen-
tration of VEGF at site x, and µ  is the strength of the chemotactic response. 
This corresponds to incorporating contact inhibition of chemotaxis, reflecting VE-
cadherins suppression of pseudopods, and extension-only chemotaxis as described in 
[52]. 
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In a similar way we implement haptotaxis, the migration towards higher ECM 
densities. One modification was made however: it would not be realistic for cells to 
move towards very high densities; therefore we include haptotactic saturation that 
ensures this restriction:  
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x x
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 (4.8) 
Here cE(x) is the local ECM density at site x, τ  is the strength of the haptotactic 
response and s is a saturation factor. 
Note that we consider concentrations of ECM components to be present at or below 
all lattice sites, so at cell sites as well, since cells are placed in the matrix and we 
consider a matrix to be present below the cell as well. 
4.5 Modeling Haptokinesis 
In chapter 2 we have described the detachment theory, the receptor saturation model 
and altered signaling to explain why cells have maximal speed, spreading and 
membrane activity at intermediate ECM densities. We translated each of these 
explanations to a model that could be incorporated into the CPM. We next ran 
simulations with a single cell placed in an in silico dish (size 400 µm x 400 µm) in a 
uniform ECM concentration to measure the average cell speed and area for a broad 
range of ECM densities. An acceptable solution should have both optimal speed and 
area (as measure of spreading) at intermediate ECM concentrations. 
4.5.1 Detachment theory in the CPM 
The detachment theory states that with a low concentration of ECM molecules there 
will be not enough adhesive forces for the cell to adhere to the matrix. On the other 
hand with high ECM densities the adhesions will be too strong to release and retract 
the rear end of the cell. We implemented this theory in the CPM by replacing the 
static adhesion energies defined for cell – matrix surfaces (JCM values) by variable 
adhesion energies. We define higher JCM values for surfaces with low ECM 
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concentrations and higher JCM values for surfaces with high concentrations at a matrix 
site (Figure 8):  
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where c is the ECM density at the matrix site, cmax and cmid are the maximum and 
intermediate ECM density, respectively. The haptokinesis parameter η defines the 
degree of deviation from the static value, with J(cmax) → 0 for η → ∞ and 
J(c) ≈ Jstatic for η = 0. 
The new adhesion energy term now reads: 
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Figure 8 Dynamic adhesion energies JCM as a function of 
ECM density. The haptokinesis strength η determines 
the slope or the extent of deviation from the static JCM 
value.. The horizontal blue line is the static JCM value. 
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In simulations where one cell was placed in a dish with uniform ECM concentrations 
we see indeed that this results in a maximal speed at an intermediate ECM 
concentration, however the area of the cell (which is a measure for spreading) 
increases with increasing ECM levels (Figure 9).  
 
 (a) (b) 
Figure 9 Testing the detachment model. Average speed 
(in µm/min) (a) and cell area (in µm) (b) of cells placed 
in different uniform ECM densities. η = 200. Error bars 
represent the standard error of the mean (s.e.m.). n = 50. 
This can very well be explained by the fact that for high JCM values cells will try to 
minimize their cell-ECM surface to minimize the energy. With decreasing JCM values, 
cells will have more affinity to attach to the matrix and will therefore increase their 
surface resulting in increased spreading. However, in extreme cases, for very low JCM 
values, the cell looses its integrity, which is another reason not to choose this model 
(Figure 10). 
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ECM density 
Figure 10 Testing the detachment model. Cell shape is 
rounded at low densities and irregular at high ECM 
densities. 
4.5.2 Receptor saturation in the CPM 
Next we implemented the receptor saturation theory in our model, which states that 
cells have a limited amount of integrins available to bind to ECM molecules. When 
the concentration of ECM molecules is low the cell cannot spread optimally. When 
the concentration is higher, spreading will increase up to a certain threshold level after 
which the spreading will decrease since all integrins of the cell can make bonds using 
less cell-matrix surface.  
We implemented this theory into the CPM by summing the ECM densities at all 
lattice sites of a cell. This total concentration is proportional to the matrix molecules 
that can bind with integrins. We define a maximum number of bonds, which is related 
to the maximum number of available integrins, the ‘saturation threshold’. The number 
of bonds of a cell is the minimum of this total ECM concentration and the saturation 
threshold: 
 maxmin( ( ), )Bonds( ) BondsEc x
σ
σ
∈
= ∑
x
 (4.11) 
Making bonds is considered favorable and therefore we introduce an energy 
difference term proportional to the difference in number of bonds before and after 
the copy attempt.  
A cell based model of ECM-guided EC migration during angiogenesis Chapter 4 
 38 
 ( )
0
Bonds( ) Bonds( )haptokinesis after beforeH
σ
η σ σ
≠
∆ = − −∑  (4.12) 
This model did show an optimal spreading at intermediate levels of collagen 
concentration, but did not result in optimal speed at those levels (Figure 11). On 
contrary, the speed decreased when spreading was optimal.  
However, when we take into account that adding a lattice site to a cell with a large 
area will have less effect on its center of mass compared to a cell with small area and 
correct the measured speed by multiplying with the area, we see an increase in speed 
at intermediate ECM densities Figure 12. However the sudden drop in speed and 
spreading doesn’t agree with experimental results. 
 
 (a) (b) 
Figure 11 Testing the receptor saturation model. Average 
speed (in µm/min) (a) and cell area (in µm) (b) of cells 
placed in different uniform ECM densities. η = 200. 
Error bars represent the standard error of the mean. 
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Figure 12 Testing the receptor saturation model. Speed × 
area as a function of ECM density. η = 200. Error bars 
represent the s.e.m. n = 50. 
4.5.3 Altered signaling in the CPM 
Finally we incorporated altered signaling in the CPM. Here the phenomenon of 
optimal spreading and motility at intermediate levels of ECM density is explained by 
differences in gene expression in the cell. When ECM concentrations exceed a certain 
level, cell behavior will change and cells will round up and loose motility. The same 
can be said for low ECM levels. Experiments have shown that cells will extend most 
protrusions at intermediate collagen levels.  
We integrated this into the CPM in the following way. When cells try to extend into 
the ECM, the probability of this step is highest at intermediate collagen levels. 
Intermediate levels will in this case result in an energy decrease, low or high levels will 
result in an increase in energy. The energy difference caused by haptokinesis is 
therefore given by the following Gaussian function (Figure 13): 
 
2
2
'
( ( ) )
20.4
,0 ,0(1 ) 1
Ec
haptokinesisH e
µ
ρ
σ σ ρδ δ η
− − 
 ∆ = − − ⋅ − +
  
x x
x
 (4.13) 
where µ  is the intermediate ECM density, (cmax-cmin)/2 and ρ is set to (cmax-cmin)/5.  
A cell based model of ECM-guided EC migration during angiogenesis Chapter 4 
 40 
 
Figure 13 The increase in energy as a function of ECM 
density. 
This results in a bell shaped curve for speed and spreading for low to high collagen 
concentration levels (Figure 14), which agrees with experimental results [28]. We 
therefore selected the altered signaling model to describe haptokinesis in the CPM.  
 
 (a) (b) 
Figure 14 Testing altered signaling. Average speed (in 
µm/min) (a) and cell area (in µm) (b) of cells placed in 
different uniform ECM densities. η = 200. Error bars 
represent the s.e.m. n = 50. 
4.6 Proliferation 
During sprouting angiogenesis stalk cells can proliferate. As described in chapter 2, 
some studies suggest that this only happens just behind the tip cell, while others argue 
that stalk cells divide at the base of a sprout. The implementation of any of these 
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options is however complicated. Since VEGF promotes proliferation and following 
the suggestion that cell division occurs at gaps between ECs [8], we allow proliferation 
for those cells for which a relatively large part of their surface is in contact with the 
ECM (and thus in contact with VEGF). The probability of mitosis grows when this 
proportion increases:   
 
min
proliferation
min min
0 , if  
, if  
P
ρ ρ
ρ ρ ρ ρ
<
= 
− ≥
 (4.14) 
where ρ is the ratio (cell-ECM surface/total cell surface) and ρmin is a threshold ratio. 
We use Hogeweg’s model [58] of cell division by assigning a new index to the grid 
points on one side of the shortest axis of the dividing cell and giving the daughter 
cells half the target area and a decreased target length. This polarized division is in 
agreement with experimental observations of proliferating ECs [59]. By slowly 
incrementing the target area and target length, cell growth is implemented. In our 
model we increase the target area of cells every 5 MCS with 2 lattice sites. 
Furthermore proliferation is only allowed outside the parent vessel, at a minimum 
distance of one cell length from the vessel wall. 
4.7 Summary 
Our cell based model of tumor induced sprouting angiogenesis uses the CPM 
framework to describe the behavior of individual endothelial cells. We added three 
layers to represent the VEGF, MMP and ECM concentrations and incorporated 
chemotaxis, haptotaxis, haptokinesis, proteolysis and proliferation as energy 
difference terms.  
The next chapter describes the results of our simulations. We will show that this 
simple model is able to reproduce realistic vascular sprouts. We use compactness, 
sprout height and sprout size as quantitative measurements to evaluate the 
consequences of varying parameters like chemotaxis, haptotaxis and haptokinesis 
strength or ECM decay rate.  
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Results 
We ran several simulations with parameter values as described in the previous chapter 
and as indicated in Table 1. We chose a relatively small diffusion coefficient and high 
decay rate for MMPs to restrict ECM degradation to the direct environment of the 
cells. We start with a very high ECM density in the dish, so cells will first need to 
break down the matrix in order to migrate. 
parameter value description 
µ 5000 chemotaxis strength 
τ 300 haptotaxis strength 
s 7 saturation haptotaxis 
η 200 haptokinesis strength 
εE_M 3e-3 decay rate ECM 
αM_V 8e-5 secretion rate MMPs 
εM 1e-3 decay rate MMPs 
DM 1e-14 diffusion coefficient MMPs 
DV 6e-11 diffusion coefficient VEGF 
εV 1e-3 decay rate VEGF 
ρmin 0.73 threshold ratio for proliferation 
λ 25 parameter area constraint 
λ’ 25 parameter length constraint 
ECM density 0.9 initial ECM density outside parent vessel 
VEGF concentration 0.05 VEGF concentration at bottom of dish 
MCS 40000 number of total MCS 
 
Table 1 Default parameter settings for simulations 
Our simulations reproduce vessel sprouts that grow towards the tumor and frequently 
form branches (Figure 15 and Figure 16). Frequently anastomosis occurs when two 
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sprouts rejoin (Figure 16 d-g). In some cases branches split off, probably due to a too 
high pulling force from the leading cells (Figure 16 g-h). 
 
 5000 10000 15000 20000 25000 30000 
Figure 15 Example of a growing sprout. Subscripts: 
number of MCS. All parameters as indicated in Table 1.  
 
 
 (a) (b) (c) (d) 
 
 (e) (f) (g) (h) 
Figure 16 Examples of growing sprouts after 30000 
MCSs. All simulations have parameter settings as 
indicated in Table 1.  
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5.1 Measuring compactness, height and size of sprout 
Although properties like sprout length and size and branching frequency can be 
evaluated upon visually inspecting the graphical output (pictures and movies) of the 
simulations, we would prefer to use quantitative measurements that can give us an 
indication of these properties in order to do a faster and more thorough analysis of 
the results.  
Before doing measurements on the growing sprout, we need to define which cells 
belong to this sprout. We therefore define the largest ‘blob’ as the largest set of 
connected cells and we will consider all cells in this blob that are outside the parent 
vessel to belong to the sprout. This means that individually migrating cells or branches 
that have split off are not included in our measurements. We use a fast union-and-find 
algorithm to determine the largest blob among all cells [60]. 
We calculate the ‘compactness’ of the sprout as a measure of branching. We first draw 
a convex hull around those cells in the largest blob that are located outside the parent 
vessel. The compactness is the ratio between the total area of these cells and the area 
of the convex hull [52]. Usually sprouts with high compactness have no or few 
branches and grow in a direct line towards the tumor. However, extensive branching 
sprouts can have high compactness as well, since these branches will at the end fill up 
almost all space.  
To measure how fast the new vessel is growing we need to measure the distance of 
the growing vascular network from the parent vessel. We define the ‘height’ of the 
sprout as the largest distance in y direction between any lattice site in the largest blob 
and the bottom of the dish.  
We are also interested in the growth in size of the sprout; we therefore define the 
‘size’ of the sprout as the number of cells of the largest blob. A large size can also be 
an indication of excessive branching. 
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5.2 Sensitivity analysis 
In order to find out which of the mechanisms of our model plays a key role in 
sprouting angiogenesis and to study the sensitivity of the model to certain parameter 
variations we ran simulations where we varied the parameter of interest and kept all 
other parameters fixed.  
5.2.1 Chemotaxis 
We first investigated the role of chemotaxis by varying the chemotaxis strength µ. 
Compactness and the size of the sprout are not sensitive to this parameter, but the 
sprout grows faster with higher values of µ (Figure 17). This makes sense, as increased 
chemotaxis will more strongly pull the growing sprout in the direction of the tumor. 
 
Figure 17 Compactness, height and size of the growing 
sprout with varying chemotaxis strength. Error bars 
indicate s.e.m. n = 10. 
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5.2.2 Haptotaxis 
Next we looked at the strength of haptotaxis. While compactness and height show no 
major differences, the size of the sprout increases with haptotaxis strength (Figure 
20), producing more complex, branching networks (Figure 18).  
 
 0 300 900 1500 
Figure 18 Examples of growing sprouts after 30000 
MCSs with different haptotaxis strength (subscripts). 
We can explain this as follows. Haptotaxis promotes migration to higher ECM 
densities, but up to an intermediate ECM concentration. The ECM density near the 
top of a sprout is higher than in areas at the sides of the sprout tip, therefore 
haptotaxis can stimulate lateral movement of (cells at) the sprout tip (Figure 19) and 
this can induce branching.  
 
 
Figure 19 Lower ECM densities at the sides of the sprout 
compared to the top. Haptotaxis to those densities can 
promote lateral movement of the sprout. 
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Figure 20 Compactness, height and size of the growing 
sprout with varying haptotaxis strength. Error bars 
indicate s.e.m. n = 8. 
5.2.3 Haptokinesis 
We next looked at haptokinesis. Here we see differences in compactness, height and 
size (Figure 21). If haptokinesis is set to zero, only small sprouts are formed, that do 
not grow much in size. For small values of haptokinesis sprouts grow very fast 
towards the tumor, with no or few branches. For larger values of haptokinesis 
strength the sprout speed decreases and more branches are formed. 
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Figure 21 Compactness, height and size of the growing 
sprout with varying haptokinesis strength. Error bars 
indicate s.e.m. n = 11. 
How can we explain this phenomenon? Without haptokinesis, the only mechanisms 
playing a role in the directional movement of cells are chemotaxis and haptotaxis. The 
VEGF gradient will stimulate cells to move towards the tumor, but apparently more is 
needed to form a growing sprout. When haptokinesis is ‘switched on’, but with a low 
strength, a sprout can be formed, and the relatively high chemotaxis strength will pull 
the sprout fast towards the tumor. With increasing haptokinesis, the migration 
forward through high ECM densities is more constrained, resulting in an increase in 
branching and a slower growing sprout (Figure 22). 
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Figure 22 Examples of growing sprouts after 30000 MCS 
with different values of chemotaxis and haptokinesis 
strength. 
5.2.4 Degradation of ECM by MMPs 
Next we investigated the role of proteolysis, the degradation of ECM components by 
MMPs. Varying the decay rate of ECM affects the compactness, height and size of the 
sprout (Figure 23 and Figure 24). 
 
 1e-3 2e-3 3e-3 4e-3 5e-3 
Figure 23 Examples of growing sprouts after 30000 
MCSs with different ECM decay rates (subscripts). 
0 5000 10000 
0 
100 
200 
chemotaxis 
haptokinesis 
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Figure 24 Compactness, height and size of the growing 
sprout with varying ECM decay rates. Error bars indicate 
s.e.m. n = 7. 
A low decay rate results in small compact sprouts that grow slowly towards the tumor. 
Increasing the decay rate produces fast growing vascular networks with a lot of 
branches. Variations in secretion rate of MMPs will have similar effects (results not 
shown). 
5.2.5 Variation in VEGF gradient 
We also varied the VEGF gradient, by varying the decay rate of VEGF, to see what 
the effect of a shallow or steep gradient will be. In all simulations the VEGF 
concentration in the parent vessel is set to the same value (0.05) to ensure that cells 
start from the same initial situation (Figure 26). 
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Figure 25 Compactness, height and size of the growing 
sprout with varying VEGF decay rates. Error bars 
indicate s.e.m. n = 7. 
Figure 25 shows an increased sprout speed for steeper gradients. However, a steep 
VEGF gradient causes a higher VEGF concentration in the dish, which in turn 
induces MMP induction. Therefore these results should for a large part be ascribed to 
increased proteolysis.   
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Figure 26 Increasing VEGF decay rates will establish 
steeper gradients.  
5.2.6 Sprout formation without proliferation 
When we do not allow cells to proliferate, branching sprouts are formed, however 
they grow must slower and parts of the sprout split off. The sprout will not reach the 
tumor (Figure 27 and Figure 28). 
 
 5000 10000 15000 20000 25000 30000    
Figure 27 Example of a growing sprout without 
proliferation.. Subscripts: number of MCS. ECM decay 
rate εE_M = 2e-3, other parameters as indicated in Table 1. 
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Figure 28 Compactness, height and size of the growing 
sprout with and without proliferation. Error bars indicate 
s.e.m. n = 40. 
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Discussion 
We demonstrated that our model, which describes cell-matrix interactions on the level 
of individual cells, is able to reproduce sprouting and branching behavior during 
angiogenesis. Most models that were discussed in chapter 3 needed specific branching 
rules to form vascular trees. Our simulation results show that our model can 
reproduce branching sprouts and networks, without including such specific rules. 
We can conclude from our sensitivity analysis that haptokinesis, the sensitivity of cells 
to ECM densities, and proteolysis, the degradation of ECM components, seem to play 
a key role in angiogenesis. Neither chemotactic migration nor haptotaxis alone appear 
to be sufficient mechanisms to form stable vascular sprouts. Their role appears to be 
more a supporting one; chemotaxis guides the growing sprout towards the tumor and 
haptotaxis promotes branch formation by stimulating lateral migration of the sprout. 
6.1 Comparing results with experimental observations 
We can validate our model when we compare our results with experimental 
observations. 
6.1.1 MMPs are essential for angiogenesis 
In our model proteolysis is required to form growing sprouts. Without ECM 
degradation cells cannot invade the matrix. This is in agreement with studies that 
demonstrate that MMPs are essential for cell migration through 3D collagen matrices 
[33]. 
6.1.2 The steepness of the VEGF gradient 
The spatial distribution of VEGF has several influences on angiogenesis. In a shallow 
VEGF gradient, tip cells will extend short undirected filopodia, resulting in a slow and 
undirected growth of sprouts. Shallow gradients will stimulate proliferation of stalk 
cells. Steeper VEGF gradients lead to excessive branching of vessels [7].  
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In our simulations with different VEGF gradients we see an increase in the speed of 
the sprout for steeper gradients. However, as discussed before, this must partly be 
ascribed to increased proteolysis. If we look at the effect of varying chemotaxis 
strength, which is similar to varying the VEGF gradient, we again see an increase in 
the speed of the sprout, but no change in branching frequency. 
6.1.3 How fast do sprouts grow? 
Many in vitro experiments observe that sprouts grow with a speed of ~ 1 mm in three 
days. This is about five times faster than our experiments. However other 
experiments [8] mention 10-12 days for sprouts to form and reach a tumor and this is 
in agreement with our observations. 
In vivo and in vitro experiments show that the speed of a sprout increases when it 
approaches the tumor [39]. In our simulations sprouts accelerate also when they 
approach the tumor. This can be ascribed to the increased secretion of MMPs due to 
higher VEGF concentrations. 
6.1.4 Cell migration and proliferation 
Experiments show that both EC migration as well as proliferation plays a role in the 
formation of vessel sprouts. If proliferation is inhibited sprouts can form, but will not 
reach the tumor [10]. Our simulations agree with this, in the first phase of 
angiogenesis the growth of the sprout is mainly caused by migrating cells, in a later 
stage proliferation is responsible for sprout growth. Furthermore, we have shown that 
without proliferation we can reproduce branching sprouts which remain small in size. 
6.1.5 Proteolysis 
Although we can question whether the endured secretion of MMPs by all cells and 
the subsequent degradation around the sprout is realistic, classic descriptions of 
extracellular proteolytic activity during angiogenesis, talk about capillary sprouts 
surrounded with a clear space, resulting from the dissolvement of fibrin [34]. In our 
model this ‘empty space’ along the stalk of the sprout is one of the main reasons for 
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the formation of small and stable sprouts. Cells are not likely to move away from the 
sprout towards very low ECM densities.  
6.1.6 Brush-border effect 
A typical phenomenon in sprouting angiogenesis is the ‘brush-border’ effect. In the 
proximity of the tumor the branching of sprouts will increase resulting in a dense 
vascular tree [39]. In our simulations we see an increase in branching half way the 
dish, but when the sprouts move further, they accelerate and move to the tumor in a 
straight line. We assume that this is due to stronger chemotaxis and to the increase in 
proteolysis caused by higher VEGF concentrations.  
The ‘brush-border’ effect could be caused by increasing stalk cell proliferation and tip 
cell selection induced by higher VEGF concentrations near the tumor. These 
phenomena are not incorporated in our model. 
According to the hypothesis of Yin and coworkers [44], increased ECM degradation 
near the tumor will decrease the haptokinetic and haptotactic effects on cell migration. 
As a result cells lose the ability to follow the ECM traces left by other cells, which 
results in increased branching. In our model the ECM density at cell sites is rather 
constant, and therefore migrating cells can follow ECM cues, even near the tumor.  
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Future work 
Improvements can certainly be made to our model. We will discuss a number of them 
in this chapter. However, when adding new rules and restrictions to the model, it will 
loose its simplicity, which is in part one of its charms. 
7.1 Adding tip and stalk cell behavior 
We can make our model more realistic by introducing two cell types: tip cells and stalk 
cells. Tip cells are more motile; they lead the sprout, navigate by extending filopodia, 
and invade the ECM by releasing proteases. Stalk cells follow the tip cells, they are less 
active, proliferate and secrete ECM components. In our current model all cells are 
sensitive to chemotactic and haptotactic cues, they can all proliferate and secrete 
MMPs and ECM components. It would make the model more realistic when we 
divide those tasks between tip cells and stalk cells.  
7.2 Proliferation induced by VEGF 
Proliferation is induced by VEGF, so we could improve the model not only by 
restricting proliferation to stalk cells, but also by increasing the probability of cell 
division with higher VEGF concentrations. 
7.3 Improving model of cell-matrix interactions 
Although we intensively studied ways to model the cell-matrix interactions, 
improvements can certainly be made. For example, in our current model we don’t 
make a distinction between the front and rear of a cell, while in reality migrating cells 
do have polarity. When cells preferably extend protrusions at their front persistence 
will be much higher.  
We studied three explanations of haptokinesis: the detachment theory, receptor 
saturation and altered signaling and finally implemented the latter in our model of 
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angiogenesis. However, we think that all three theories (and maybe others) play a role 
in haptokinesis and it would be interesting to look further into the underlying 
mechanisms. 
In our model degradation of ECM proteins is not regulated in the sense that the 
secretion of MMPs and the degradation of ECM by MMPs are not related to the 
ECM density in the direct environment of the cell. However, in reality, cells can fine-
tune proteolysis to prevent excessive break down of the matrix. We could therefore 
add functionality to the model that inhibits or limits proteolysis when ECM densities 
are low enough for invasion. 
Other mechanisms that influence the migration of cells could be included in the 
model. For instance shear stress, matrix rigidity and the direction of matrix fibers, can 
all guide cells when migrating into the matrix. Cells in their turn can remodel the 
fibers in the ECM leaving cues for following cells.  
7.4 Improving the representation of the ECM 
The ECM is now modeled as a field with initially a uniform concentration of ECM 
components. In reality the matrix is heterogeneous with irregular concentrations of 
different molecules. In our model we do not make any distinction between different 
ECM proteins, we generally refer to ECM components and don’t have in particular 
collagen, fibronectin in mind. Including these distinct components with their specific 
properties will also make the model more realistic.   
We could furthermore add matrix bound factors to the ECM, such as certain VEGF 
isoforms, which can be released or activated by MMPs. These factors will set up steep 
local gradients and this will certainly affect cell migration [33]. 
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7.5 Quantitative validation 
Most of our model parameters have no relation with physical parameters, and 
therefore a quantitative validation of the model is difficult. In order to make our 
model more realistic, we could for instance use realistic concentrations of VEGF, 
MMPs and ECM densities. Other values of interest are measurements concerning 
proteolysis, such as the induction of MMPs by VEGF or the degradation of ECM 
components by MMPs. Are these relations linear, like in our model?  
Measurements on growing and branching sprouts could help to make our model 
more realistic. For example, if we would have more quantitative data from 
experimental observations relating to the effect of VEGF gradients and ECM 
densities and gradients on sprout growth and branching, we could use this 
information to further calibrate our model 
We could use existing imaging analysis tools to measure for example the number and 
length of branches in a sprout. The same tools can be used to analyze images from in 
vitro or in vivo experiments. This way we can better compare our results with 
experimental observations. 
.   
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